BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7064851)

  • 1. Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.
    Gagnon RM; Morissette M; Présant S; Savard D; Lemire J
    Am J Cardiol; 1982 Apr; 49(5):1267-9. PubMed ID: 7064851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. I.v. labetalol in the treatment of hypertension following coronary-artery surgery.
    Morel DR; Forster A; Suter PM
    Br J Anaesth; 1982 Nov; 54(11):1191-6. PubMed ID: 7138722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Postgrad Med J; 1980; 56 Suppl 2():21-6. PubMed ID: 7433338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Labetalol for the management of hypertensive crises during surgery of cerebral aneurysm; a haemodynamic study (author's transl)].
    Lüben V; Rieder W; Zierski J; Hempelmann G
    Anasth Intensivther Notfallmed; 1981 Aug; 16(4):184-7. PubMed ID: 7294326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.
    Rude RE; Turi Z; Brown EJ; Lorell BH; Colucci WS; Mudge GH; Taylor CR; Grossman W
    Circulation; 1981 Jul; 64(1):139-45. PubMed ID: 7237712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease.
    Silke B; Nelson GI; Ahuja RC; Taylor SH
    Br Heart J; 1982 Oct; 48(4):364-71. PubMed ID: 7126388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of combined alpha and beta blockade with labetalol on the haemodynamics of stress reaction in hypertensives (author's transl)].
    Bahlmann J; Brod J; Hubrich W; Pretschner P
    Dtsch Med Wochenschr; 1980 Oct; 105(41):1414-8. PubMed ID: 7449643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of labetalol, a new alpha- and beta-adrenoceptor blocking agent, in humans.
    Vas A; Gachályi B; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):491-2. PubMed ID: 7141757
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies.
    Scardo JA; Vermillion ST; Newman RB; Chauhan SP; Hogg BB
    Am J Obstet Gynecol; 1999 Oct; 181(4):862-6. PubMed ID: 10521743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of arterial hypertension with labetalol. A polycentric study].
    G Ital Cardiol; 1982; 12(10):729-35. PubMed ID: 7182212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol.
    Baum T; Watkins RW; Sybertz EJ; Vemulapalli S; Pula KK; Eynon E; Nelson S; Vliet GV; Glennon J; Moran RM
    J Pharmacol Exp Ther; 1981 Aug; 218(2):444-52. PubMed ID: 7252843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: a placebo-controlled study.
    Pornin M; Harpey C; Allal J; Sellier P; Ourbak P
    Clin Trials Metaanal; 1994 Apr; 29(1):49-56. PubMed ID: 10150185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and hemodynamic effects of peptide leukotriene C4 and D4 in man.
    Vigorito C; Giordano A; Cirillo R; Genovese A; Rengo F; Marone G
    Int J Clin Lab Res; 1997; 27(3):178-84. PubMed ID: 9352380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of labetalol on intracranial pressure in dogs with and without intracranial hypertension.
    Van Aken H; Puchstein C; Schweppe ML; Heinecke A
    Acta Anaesthesiol Scand; 1982 Dec; 26(6):615-9. PubMed ID: 7158271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of labetalol on myocardial contractile function in brain-dead pigs.
    Siaghy EM; Halejcio-Delophont P; Devaux Y; Richoux JP; Villemot JP; Burlet C; Ungureanu-Longrois D; Mertes PM
    Transplant Proc; 1998 Sep; 30(6):2842-3. PubMed ID: 9745589
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of ketanserin on central haemodynamics and coronary circulation.
    Hood S; Birnie D; Nasser A; Hillis WS
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):983-7. PubMed ID: 9869505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans.
    Boehrer JD; Moliterno DJ; Willard JE; Hillis LD; Lange RA
    Am J Med; 1993 Jun; 94(6):608-10. PubMed ID: 8506886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral blood flow measurements during blood pressure control with intravenous labetalol following craniotomy.
    Dubois M; Caputy A; MacCosbe P; Lea D; Duma C
    J Neurosurg Anesthesiol; 1992 Jul; 4(3):176-81. PubMed ID: 15815460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of high-dose intravenous labetalol in hypertensive crisis.
    Hecht JP; Mahmood SM; Brandt MM
    Am J Health Syst Pharm; 2019 Feb; 76(5):286-292. PubMed ID: 30753292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The electrophysiological effects of intravenous labetalol in man.
    Harley A; Coverdale HA
    Eur J Clin Pharmacol; 1981; 20(4):241-4. PubMed ID: 7308279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.